flecainid-ratiopharm tablett
merckle gmbh - flekainiid - tablett - 100mg 100tk
flecainidacetat puren tablett
apl swift services ltd - flekainiid - tablett - 100mg 50tk
tambocor süstelahus
meda ab - flekainiid - süstelahus - 10mg 1ml 15ml 5tk
aristocor süstelahus
cenexi sas - flekainiid - süstelahus - 10mg 1ml 15ml 5tk
tambocor süstelahus
weimer pharma gmbh - flekainiid - süstelahus - 10mg 1ml 15ml 5tk
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic kasvajad, kastreerimine-vastupidavad - antineoplastilised ained - treatment of adult patients with prostate cancer.
agenerase
glaxo group ltd. - amprenaviir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - agenerase kombinatsioonis teiste retroviirusevastaste ravimitega on näidustatud proteaasi inhibiitori (pi) raviks hiv-1 nakatunud täiskasvanutel ja üle 4-aastastel lastel. agenerase kapsleid tuleb tavaliselt manustada amprenaviiri farmakokineetilise võimendajana koos ritonaviiri väikeste annustega (vt lõigud 4. 2 ja 4. amprenaviiri valik peaks põhinema patsiendi individuaalsel viiruse resistentsustestil ja patsiendi ravi ajaloos (vt lõik 5). kasu agenerase võimendatud koos ritonaviiri ei ole tõendatud, pi nave patsientidel (vt lõik 5.
abiraterone mylan
mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.